Empagliflozin + Linagliptin

DRUG2 trials

Sponsors

Boehringer Ingelheim, EMS

Conditions

Diabetes Mellitus, Type 2Type 2 Diabetes Mellitus

Phase 3

Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 Diabetes

CompletedNCT01734785

Boehringer IngelheimDiabetes Mellitus, Type 2

Start: 2013-02-08End: 2015-03-23Updated: 2024-09-19

Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus

RecruitingNCT04670666

EMSType 2 Diabetes Mellitus

Start: 2024-11-18End: 2027-06-30Target: 270Updated: 2025-12-08